The estimated Net Worth of Sara J White is at least $2.93 Milhão dollars as of 21 February 2017. Ms. White owns over 3,443 units of Omnicell stock worth over $2,009,517 and over the last 21 years she sold OMCL stock worth over $645,459. In addition, she makes $276,967 as Independent Director at Omnicell.
Sara has made over 16 trades of the Omnicell stock since 2004, according to the Form 4 filled with the SEC. Most recently she exercised 3,443 units of OMCL stock worth $148,290 on 21 February 2017.
The largest trade she's ever made was selling 17,500 units of Omnicell stock on 13 December 2010 worth over $267,050. On average, Sara trades about 2,592 units every 113 days since 2003. As of 21 February 2017 she still owns at least 46,657 units of Omnicell stock.
You can see the complete history of Ms. White stock trades at the bottom of the page.
Sara J. White is an Independent Director of Omnicell Inc. Since April 2004, Ms. White has served as a director of Omnicell since April 2003. Since April 2004, Ms. White has served as a pharmacy leadership coach. From 1992 to March 2004, Ms. White was a clinical professor at the School of Pharmacy at the University of California, San Francisco. From 1995 to March 2004, Ms. White was an adjunct professor at the University of the Pacific, School of Pharmacy. From 1992 to 2003, Ms. White was the Director of Pharmacy at Stanford Hospital and Clinics. Ms. White received a B.S. in pharmacy from Oregon State University and an M.S. and Residency in hospital pharmacy management from Ohio State University.
As the Independent Director of Omnicell, the total compensation of Sara White at Omnicell is $276,967. There are 14 executives at Omnicell getting paid more, with Randall Lipps having the highest compensation of $7,208,970.
Sara White is 74, she's been the Independent Director of Omnicell since 2003. There are no older and 19 younger executives at Omnicell.
Sara's mailing address filed with the SEC is OMNICELL, INC., 4220 NORTH FREEWAY, FORT WORTH, TX, 76137.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps, eBenjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: